SAN FRANCISCO (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its ...
Those factors aren’t expected to be much of an issue in UnitedHealth’s latest numbers, due out very early Thursday. But they’re factors to monitor later in the morning, when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback